Frunevetmab, sold under the brand name Solensia, is a monoclonal antibody used to treat pain associated with osteoarthritis in cats.
[3] When frunevetmab binds to nerve growth factor, it prevents the pain signal from reaching the brain.
[3][4] The most common side effects seen in cats include vomiting, diarrhea, injection site pain, scabbing on the head and neck, dermatitis, and pruritus (itchy skin).
[3][6] Development as a potential drug for humans was stopped due to risk concerns over worsening osteoarthritis.
[7] This article incorporates public domain material from the United States Department of Health and Human Services